$50m final close for Vitalife debut

A year after its initial close, the Israeli life sciences firm has held a $50m final close for its inaugural fund, following a significant commitment from US private equity funds-of-funds manager HarbourVest Partners.

ByPEI Staff

30 December 2012•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Middle East Middle East & North Africa North America Western Europe

$50m final close for Vitalife debut

HarbourVest Partners

Jerusalem Global Ventures

Related articles